The closing of the business combination with PowerUp Acquisition Corp. creates Nasdaq-listed biopharmaceutical company dedicated to developing breakthrough innovations in FDA approved drugs, ...

Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (the “Company”), a pharmaceutical company focused on developing new medicines for infectious diseases, announced today that it will effect a 1-for-5 ...

Aspire Biopharma (ASBP) and PowerUp Acquisition (PWUP) announced the completion of their previously announced business combination. Proceeds ...

The biotech’s lead drug candidate is in Phase 3 testing in Prader-Willi syndrome, a genetic disorder that causes persistent hunger leading to overeating.

Attendees of the $349 “ Don’t Die Summit ” at the west side’s Javits Center tried red light therapy, discovered their ...

Iterum Therapeutics plc (NASDAQ:ITRM), a pharmaceutical company with a market capitalization of $53.43 million, has reported a regulatory compliance issue with the Nasdaq Stock Market. According to ...

The company hopes to list its shares on Nasdaq under the symbol AAPG. Lead bookrunners ... Ascentage (AAPG) hopes to file for FDA approval of the product in 2026.

Those shares will trade on the Nasdaq under the stock symbol “AAPG.” The only commercialized Ascentage product is olverembatinib, a drug approved ... to support an FDA new drug application ...

Beta Bionics (BBNX) hopes to list its shares on Nasdaq under the symbol BBNX ... The product has been approved by the FDA for the treatment of type 1 diabetes. Beta Bionics (BBNX) hopes to ...

2. Clarity Pharmaceuticals. Clarity receives U.S. FDA Fast Track Designation for 64Cu-SAR-bisPSMA in biochemical recurrence of prostate cancer. https://www.claritypharmaceuticals.com/news/ftd-2/ ...

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United Kingdom (UK) ...

Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...